Roche is a leading healthcare company that has for over 100 years been active in the discovery, development, manufacture and marketing of healthcare solutions. Our products and services address prevention diagnosis and treatment of diseases, thus enhancing well-being and quality of life.

Established in 1932 and headquartered in Newton, Massachusetts, Barclay Water Management, Inc. is the leading middle market water treatment supplier. We provide value to our customers by reducing their water and energy consumption while protecting the watersides of critical heat exchange equipment. Our proprietary formulations are manufactured in Company-owned ISO-9001 certified facilities and our employees are committed to total customer satisfaction. The Environmental Group, a division of Barclay Water Management, provides a range of water hygiene products and services including Legionella testing, Building Water Management Plans, cooling tower and ice machine cleaning services, as well as secondary disinfection of potable water systems utilizing monochloramine, and other technologies. Barclay Water Management, Inc. is the oldest and largest employee-owned water treatment firm in North America and was named one of America’s Top Workplaces by The Wall Street Journal. Our employees are the best educated and most experienced water treatment professionals in the industry and for more than three quarters of a century we’ve remained financially sound and customer driven. Our employee-owners enjoy a generous profit-driven compensation plan and benefit package which includes the opportunity to acquire a substantial equity ownership in our business through our Employee Stock Ownership Plan (ESOP).

Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for virology and immunology indications. Enanta’s research and development programs are currently focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU) and the company has previously advanced clinical-stage compounds for SARS-CoV-2 (COVID-19) and chronic hepatitis B virus (HBV) infection. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET® (U.S.) and MAVIRET® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta’s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta’s operations. Please visit www.enanta.com for more information.

Twin Rivers Technologies is one of the largest Oleochemical producers in North America. We provide solutions that deliver superior quality, service, and value to our customers. The relationships we have developed with our customers and within our communities are based on open communications, trust, and delivering only one standard of performance -- "the best in all that we do."​ Twin Rivers Technologies is focused on satisfying our customers and growing our business. Our foundation is firmly established in creating a safe, clean and compliant atmosphere for our employees and communities. We have developed core competencies in designing and implementing flexible business structures and organizations. Technological know-how and supply chain expertise are our core competencies. Visit our blog at http://blog.twinriverstechnologies.com/blog

We add the “performance” to a vast variety of products that are part of our daily lives, from the car you drive to the chips in your computer. Chances are, not a day goes by that you do not use a product that contains or has been manufactured using a King additive. While our additive functions are technical by nature, in short these specialty chemicals impart desirable, value-added properties to the end uses they are apart of. Whether a King catalyst used to cure an automotive coating while saving energy or a King rust preventive extending a lubricant’s life, they indeed add the performance that a consumer expects from their product choices. Often used at levels as low as parts per million, King additives, are an integral component to formulations of some of the biggest names in the chemical, rubber and oil industries worldwide. While many have been loyal customers for decades, we are constantly challenged by them and others to develop new products that provide even higher standards of performance. It is this challenge of providing innovative high performance additives that drives our business

Nagase is a global leader in innovative products and solutions through our expertise in the fields of chemicals, plastics, electronics, automotive, and life sciences. We believe in the power of bringing together good science with great people to create customized solutions for the world’s changing economic, environmental, and social needs. Founded in Japan in 1832, the Nagase Group has grown to over 6,000 employees in 20 countries. The company’s U.S. corporate headquarters are located in New York City. The Nagase Group has net sales of over $8 billion. Nagase & Co., Ltd. is listed on the Tokyo Stock Exchange.

Bedoukian Research, Inc. is a 100% family owned company that provides world-class technical support and customer service. Our company was founded in 1972 to fill a niche as a supplier of high quality specialty aroma molecules. Today, we offer more than 350 high impact fragrance and flavor ingredients, while providing custom manufacturing services to the pharmaceutical and specialty chemical industries. We strive to minimize our impact on the environment, improve our processes and efficiency, and of course, to innovate our next exciting high impact ingredients. Our employees are our greatest resource, and it is their personal involvement in these goals that leads to our industry leading reputation for quality and service. To learn more about Bedoukian Research, please visit us at bedoukian.com.

Every day 30 million people benefit from Kuehne Company’s water treatment products. Since 1919, our family-owned company has delivered the reliability and quality that our customers need and trust. We are all about people and our planet, and from our truck drivers to our scientists, everything we do is focused on safety, efficiency, quality, health and environmental sustainability. Our voice is active in the national institutes that govern our industry, and we continue to strive for a better, clearer (planet) future.

WE'RE ALL IN FOR FIGHT AGAINST CANCER Partner Therapeutics is devoted to developing and commercializing cancer medicines and combination therapies that can make a meaningful difference in the lives of cancer patients. We are united in our passion for improving the treatment of cancer and our desire to make a meaningful contribution to outcomes. THE PATIENT IS NUMBER ONE We believe that being a cancer company begins and ends with the patient. We strive to support patient needs throughout their treatment journey to help them make the treatment choices that are right for them and their loved ones. FIGHTING CANCER IS TEAM SPORT We believe that cancer is a complex, dynamic disease that requires a multi-faceted, multi-disciplinary approach to tackle. We believe in teamwork at each stage of a therapy’s development, and seek to build teams of experts, both internally and externally, that cover the breadth and depth of the complex problem that is cancer. We work with leading companies and investigators to ensure that our products are tested in the best settings, and in combination with highest potential regimens to maximize benefit to patients and to advance the understanding of cancer treatment. We seek to engage all members of the cancer treatment team as well as thought-leading physicians and patient advocacy organizations to ensure that clear, complete and balanced information about our products is proactively communicated and readily available. We work to support the extraordinary dedication of the medical teams that represent the front lines in the war on cancer. OUTCOMES ARE OUR YARDSTICK We believe that innovation is not enough. In the challenging world of today’s healthcare climate, we strive to develop and assess our products based on the real-world impact they have in improving the quality and duration of our patients’ lives. We measure our success in the birthdays, anniversaries and other important life moments that our patients are able to enjoy.

Grant Industries engages in the research, development, manufacturing, and marketing of textile, cosmetic, and performance specialty chemicals. We serve all major global cosmetic markets and are known for our award-winning products, cutting-edge research and personalized customer care. Our dedication to product performance and customer support makes us the ideal source for state-of-the-art ingredients to improve your product's skin feel. Our main product categories include: polysilicone-11 elastomer gels, silicone/active powders, microsphere powders, surfactants, UV dispersions, specialty silicone fluids and formulated cosmetic ingredients. Additional information on the company and its products are available on the web site grantinc.com Technical Support? [email protected]

With roots from 1849, Hubbard-Hall’s mission is to help manufacturers tackle complex surface finishing and wastewater treatment problems. Combining 6 generations of family leadership, 3 strategically located facilities and a 99.8% product consistency goal, we are performance driven and customer focused. We develop, service and supply our line of specialty chemicals for ferrous and non-ferrous metals which include pretreatment specialties, cleaners, corrosion inhibitors, metal & paint strippers, conversion coatings, phosphates, mass finishing, wastewater treatment, metal colorants, heat treatment and rubber curing salts.